The global acute agitation and aggression therapeutics market is booming, projected to reach $2328.5 million by 2025 with a 5.7% CAGR. Discover key drivers, trends, and regional insights in this comprehensive market analysis, featuring leading companies like Eli Lilly and Pfizer. Explore oral, intramuscular, and other treatment options across various care settings.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
